Restless legs syndrome in Friedreich ataxia: A polysomnographic study

Movement Disorders

Volumn 26, Issue 2, 2011, Pages 302-306

  Frauscher, Birgit ^a   Hering, Sascha ^a   Högl, Birgit ^a   Gschliesser, Viola ^a   Ulmer, Hanno ^a   Poewe, Werner ^a   Boesch, Sylvia M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ferritin; Friedreich ataxia; Periodic leg movements; Polysomnography; Restless legs syndrome; Sleep disturbance

Indexed keywords

FERRITIN;

ADULT; APNEA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; FRIEDREICH ATAXIA; HUMAN; IRON METABOLISM; LEG CRAMP; MALE; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SLEEP PATTERN; SNORING; WAKEFULNESS;

ADULT; ANALYSIS OF VARIANCE; FEMALE; FERRITINS; FRIEDREICH ATAXIA; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SLEEP; STATISTICS, NONPARAMETRIC;

EID: 79952688979     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22769     Document Type: Article

References (38)

1. Cossée M, Schmitt M, Campuzano V, et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci USA 1997; 94: 7452-7457.
2. Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet 2000; 37: 1-8.
3. Harding AE. Friedreich ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981; 104: 589-620.
4. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-1427.
5. Pandolfo M, Pastore A. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol 2009; 256(Suppl1): 9-17.
6. Li K, Besse EK, Ha D, Kovtunovych G, Rouault TA. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum Mol Genet 2008; 17: 2265-2273.
7. Schulz JB, Boesch S, Bürk K, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol 2009; 5: 222-234.
8. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006; 66: 1717-1720.
9. Lynch DR, Farmer JM, Tsou AY, et al. Measuring Friedreich ataxia: complementary feature of examination and performance measures. Neurology 2006; 66: 1711-1716.
10. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119.
11. Hening W, Allen RP, Washburn M, Lesage SR, Earley CJ. The four diagnostic criteria for restless legs syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 2009; 10: 976-81.
12. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-32.
13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
14. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute; 1968.
15. Mahowald MW, Schenck CH. REM sleep behaviour disorder. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, Second ed. Philadelphia: W.B. Saunders Company; 1994. p 574-588.
16. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder. Neurology 1992; 42: 1371-1374.
17. Bliwise DL, He L, Ansari FP, Rye DB. Quantification of electromyographic activity during sleep: a phasic electromyographic metric. J Clin Neurophysiol 2006; 23: 59-67.
18. Zucconi M, Ferri R, Allen R, et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006; 7: 175-183.
19. International classification of sleep disorders, Second ed.Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
20. Iber C, Ancoli-Israel C, Chesson A, Quan SF; American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, First ed. Westchester, Illinois: American Academy of Sleep Medicine; 2007.
21. Högl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology: 2005; 64: 1920-1924.
22. De Biase I, Rasmussen A, Endres D, et al. Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients. Ann Neurol 2007; 61: 55-60.
23. Clemens S, Rye D, Hochman S. Restless legs syndrome. Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006; 67: 125-130.
24. Paulus W, Dowling P, Rijsman R, et al. Update on the pathophysiology of the restless-legs-syndrome. Mov Disord 2007; 22 (Suppl 18): S431-S439.
25. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide assocation study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000-1006.
26. Wilson RB, Lynch DR, Fischbeck KH. Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. Ann Neurol 1998; 44: 132-134.
27. Gordon N. Friedreich's ataxia and iron metabolism. Brain Dev 2000; 22: 465-468.
28. Popescu BF, Pickering IJ, George GN, Nichol H. The chemical form of mitochondrial iron in Friedreich's ataxia. J Inorg Biochem 2007; 101: 957-966.
29. Becker E, Richardson DR. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich ataxia. Int J Biochem Cell Biol 2001; 33: 1-10.
30. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007; 22(Suppl 18): S440-S448.
31. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003; 61: 304-309.
32. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004; 62: 1563-1567.
33. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54: 1698-1700.
34. Frauscher B, Gschliesser V, Brandauer E, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient population: association with ferritin levels. Sleep Med 2009; 10: 611-615.
35. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23: 200-203.
36. Pennestri MH, Whittom S, Adam B, et al. PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution. Sleep 2006; 29: 1183-1187.
37. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless legs syndrome. Mov Disord 1998; 13: 324-329.
38. Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. Clin Neurophysiol 1999; 110: 1168-1174.